NEW DELHI: India on Sunday banned the export of antiviral drug Remdesivir and its active pharmaceutical ingredients as demand rocketed due to a record surge in COVID-19 infections and led to crippling shortages in many parts.
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month, for local use and exports to more than 100 countries. India's tally of more than 13.35 million cases is the third-highest globally, behind only the United States and Brazil.India's drug regulator and some state governments have in recent days raised concerns over hoarding and black marketing of Remdesivir, which in some instances is being sold at more than 10 times the maximum retail price.
"Rostering of health care workers, hiring of contractual health workers need to be expedited," the letter from India's top health bureaucrat said, flagging an acute shortage of healthcare workers in seven districts of Maharashtra.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.